update Updates

Biomet, Inc. to Settle Hip Implant Suits for $56 Million

Biomet Inc. has agreed to pay at least $56 million to settle pending lawsuits over the embattled M2a Magnum hip implants according to documents filed in the federal consolidation of cases (no. MDL 2391; U.S. District Court Northern District of Indiana). There are about 800 Biomet lawsuits pending in federal court … Read more

Federal Court Releases New Leadership Order in Biomet Lawsuits

A federal court in Indiana recently ordered a new deadline for the reappointment and appointment of individuals to the plaintiffs’ steering committee in the federal consolidation of Biomet lawsuits according to court documents. The Rottenstein Law Group LLP discusses the news and how it could impact those who have filed or are looking to file… Read more

Number of Pending Federal Biomet Lawsuits Reaches Nearly 800

There are nearly 800 Biomet hip lawsuits in federal court in Indiana as of Nov. 18 according to court documents. The Rottenstein Law Group LLP notes that reported problems with metal-on-metal hip implants industry-wide have led to a major actions involving a handful of medical device manufacturers including Biomet and DePuy Orthopaedics maker… Read more

Number of Biomet Hip Lawsuits Increases in Federal Courts

There are now more than 650 Biomet hip lawsuits pending in federal courts an increase of about 70 from August according to court documents. The Biomet lawsuits were consolidated in the U.S. District Court for the Northern District of Indiana before Judge Robert L. Miller in order to increase pretrial… Read more

Judge Denies Biomet Motion to Dismiss Hip Lawsuit

A judge in Indiana federal district court denied a Biomet bid to throw out a lawsuit against the company on Aug. 28 according to court documents. Plaintiff Leslie Caccia alleges in the suit that his Biomet implant was faulty and caused him bone and tissue damage necessitating corrective surgery … Read more

DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants

Johnson & Johnson subsidiary DePuy Orthopaedics announced on May 16 that it will stop sales of metal-on-metal hip replacements. This comes after the company saw the market for the products drop significantly amid lawsuits and calls for increased regulation and after the 2010 recall of the DePuy ASR hip implant. Johnson… Read more

Rottenstein Law Group Encouraged by Medical Device Safety Reporting App

The U.S. Food and Drug Administration has authorized a smartphone app for doctors to more easily report safety issues with high-risk medical devices such as metal-on-metal hip replacements according to the Wall Street Journal. RLG maintains a Hip Replacement Lawsuit Center that offers information on hip implants and filing a hip lawsuit and represents clients in… Read more

Next Biomet MDL Case Management Conference Scheduled for Feb. 4

Proceedings in the Biomet hip replacement multidistrict litigation in Indiana will continue on Feb. 4 RLG reports. According to court records from the case (MDL-2391 U.S. District Court for the Northern District of Indiana) another case management conference is scheduled for 1 p.m. on Feb. 4 in South Bend Ind. A CMC… Read more

RLG Favors Consolidation of Federal Biomet Hip Lawsuits

The Rottenstein Law Group which represents clients with claims stemming from the failures of defective hip replacement devices manufactured and sold by various companies is in favor of consolidation of lawsuits against Biomet notwithstanding the opposition of the company. An attorney for the Rottenstein Law Group attended the conference… Read more

RLG Disappointed by Outcome of FDA’s Hip Implant Meeting

The Rottenstein Law Group is frustrated by the FDA’s failure to take aggressive measures to protect patients from metal-on-metal hip implants despite the negative opinions of the devices expressed by experts at a special meeting convened by the FDA this week. At the FDA meeting which took place on June 27… Read more

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.